Last reviewed: June 6, 2026
Last updated: June 6, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has become a powerful tool for chronic weight management. Clinical trials show that people who stop semaglutide typically regain weight within months, meaning treatment duration depends on individual goals and medical history rather than a fixed endpoint. PlexusDx offers compounded semaglutide injection starting at $149/month, making long-term access more affordable for patients seeking sustained results.
How Long Do People Stay on Semaglutide?
There is no predetermined time limit for semaglutide therapy. Weight management experts increasingly view GLP-1 medications as long-term treatments similar to blood pressure or cholesterol drugs—something you may take for years or indefinitely to maintain your desired outcome. A landmark clinical trial published in the New England Journal of Medicine showed that participants who continued semaglutide after reaching their weight loss goal kept weight off, while those who stopped regained an average of two-thirds of the weight they had lost within one year.
Your specific treatment duration depends on how your body responds, whether you reach your weight loss targets, and your ability to maintain results with lifestyle changes alone. Some patients use semaglutide for 6 to 12 months to jump-start weight loss and build new habits, then transition to maintenance doses or stop with close medical monitoring. Others benefit from ongoing treatment indefinitely to prevent weight regain and manage appetite signals. PlexusDx providers work with you to set realistic timelines and adjust your semaglutide plan as your needs evolve.
Weight Regain After Stopping Semaglutide
When people discontinue semaglutide, appetite hormones and metabolic signals gradually return to baseline levels, typically within weeks to months. This is not a failure—it reflects the biology of how the medication works. GLP-1 receptors control hunger signals in your brain, and stopping the medication removes that chemical support, meaning your body reverts to its previous appetite set point. Research shows that without continued use or significant lifestyle intervention, most weight returns within 6 to 12 months.
The key takeaway is that semaglutide addresses a chronic condition: weight regulation difficulty. Just as a person with high blood pressure cannot stop their medication and expect permanent results, semaglutide users who want to keep weight off generally need ongoing treatment. This does not mean the same dose forever—many patients find success with lower maintenance doses after reaching their initial target. PlexusDx structures pricing so your dose may increase during weight loss phases, but your monthly cost stays flat across commitment tiers, eliminating financial barriers to long-term therapy.
Typical Semaglutide Treatment Timeline
Most patients begin with a low starting dose and gradually increase over 4 to 6 weeks during a titration phase. This slow ramp-up reduces nausea and allows your body to adapt to the medication's effects. During the first 3 months, you typically see measurable weight loss as appetite suppression kicks in and you naturally eat fewer calories. By months 3 to 6, many patients reach their most significant weight loss velocity, often dropping 5% to 10% of their starting body weight.
Months 6 to 12 represent a consolidation phase where weight loss may slow but continues, and you build sustainable eating and activity habits alongside the medication. Beyond one year, many patients stabilize at a lower weight and either continue at a maintenance dose or work with their provider to assess whether gradual dose reduction is appropriate. The entire process is individualized—some reach their goals in 6 months, while others need 18 to 24 months. PlexusDx's Precision Peptide Genetic Test can identify your genetic peptide pathway profile, helping predict how you may respond to semaglutide and whether combination therapy might work better for your unique metabolism.
When and How to Stop Semaglutide Safely
Stopping semaglutide should be a planned decision made with your healthcare provider, not an abrupt halt. If you decide to discontinue, your provider may recommend a gradual taper rather than stopping immediately, especially if you have been on the medication for many months. There is no physical dependence on semaglutide—your body will not experience dangerous withdrawal—but a gradual transition allows you to monitor how your appetite and weight respond and adjust lifestyle strategies as needed.
Candidates for stopping semaglutide are typically those who have maintained significant weight loss over at least 6 to 12 months, have developed strong dietary and exercise habits, and feel confident managing appetite without medication. Even then, periodic reassessment is wise because weight regain can occur silently over months. Some patients successfully remain off semaglutide long-term by committing intensively to diet and activity; others find that resuming treatment after a trial off-medication is the most effective strategy. PlexusDx makes restarting simple and affordable—your semaglutide injection costs remain consistent whether you are beginning, maintaining, or resuming therapy, so cost does not become a barrier to making the best health choice for your individual situation.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I use semaglutide for just three months and then stop permanently?
Stopping semaglutide after three months typically results in weight regain because the medication's appetite-suppressing effect ends once you discontinue it. Clinical data shows most patients regain two-thirds of lost weight within a year of stopping. Long-term treatment or robust lifestyle changes are usually needed to maintain results.
Do clinical trials show semaglutide works as a permanent weight loss solution?
No. The major STEP trials demonstrated that semaglutide's weight loss benefit persists only while taking the medication. Participants who stopped regained weight rapidly, while those who continued maintained their loss. This positions semaglutide as chronic therapy, similar to medications for diabetes or hypertension.
What is the average cost of staying on semaglutide long-term with PlexusDx?
PlexusDx compounded semaglutide injection starts at $149/month, a flat rate regardless of your dose level. This predictable pricing makes long-term treatment accessible—your dose may increase during active weight loss, but your monthly cost stays the same across commitment tiers.
Is semaglutide safe to use for one year or longer?
Yes. Clinical trials and real-world data support semaglutide safety over 1 to 2+ years of continuous use. The most common side effects—nausea, constipation, and appetite loss—tend to improve after the first few weeks. Serious side effects are rare when prescribed appropriately. Your PlexusDx provider monitors your progress regularly.
Can the Precision Peptide Genetic Test predict how long I will need semaglutide?
The PlexusDx Precision Peptide Genetic Test identifies your genetic variants in peptide pathways (GLP1R, GIPR, FTO, MC4R and 46 others), helping predict your baseline appetite regulation and medication response. This insight can guide whether semaglutide alone, a dual-compound like GLP-Squared, or a different approach suits you best, potentially affecting treatment duration and success.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What Will Happen to Compounded Semaglutide?
Does Wegovy Work as Good as Ozempic? Exploring the Similarities and Differences